Overall market sentiment has been high on Aslan Pharmaceuticals Ltd (ASLN) stock lately. ASLN receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With ASLN Stock Today?
Aslan Pharmaceuticals Ltd (ASLN) stock is trading at $1.71 as of 3:00 PM on Thursday, Sep 24, a drop of -$0.21, or -10.94% from the previous closing price of $1.92. The stock has traded between $1.66 and $1.85 so far today. Volume today is high. So far 106,077 shares have traded compared to average volume of 63,702 shares.
To screen for more stocks like Aslan Pharmaceuticals Ltd click here.
More About Aslan Pharmaceuticals Ltd
ASLAN Pharmaceuticals Ltd is a clinical-stage immunology and oncology-focused biopharmaceutical company. It is engaged in developing treatments to transform the lives of patients. The company has a clinical portfolio comprised of a first in class monoclonal therapy, ASLAN004, that is being developed in atopic dermatitis and other immunology indications, and a small molecule inhibitor targeting oncology.
Click Here to get the full Stock Score Report on Aslan Pharmaceuticals Ltd (ASLN) Stock.
